๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Post-therapy change in prostate-specific antigen levels as a clinical trial endpoint in hormone-refractory prostatc cancer: A trial with 10-ethyl-deaza-aminopterin

โœ Scribed by Paul K. Schultz; W. Kevin Kelly; Colin Begg; Christine Liebertz; Lee Cohen; Howard I. Scher

Book ID
119486229
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
653 KB
Volume
44
Category
Article
ISSN
0090-4295

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase 3 randomized trial evaluating seco
Phase 3 randomized trial evaluating second-line hormonal therapy versus docetaxel-estramustine combination chemotherapy on progression-free survival in asymptomatic patients with a rising prostate-specific antigen level after hormonal therapy for prostate cancer: an Eastern Cooperative Oncology Group (E1899), intergroup/clinical trials support unit study
โœ Janet R Walczak; Michael A Carducci ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 113 KB